Loading...
Lantus, Basaglar, Toujeo
Antidiabetic • Long-acting insulin analog
Binds to insulin receptors, promoting glucose uptake and inhibiting hepatic glucose production
Drug Class
Antidiabetic
Subclass
Long-acting insulin analog
Half-life
24 hours (duration)
Time for plasma concentration to decrease by 50%
Protein Binding
5%
Fraction bound to plasma proteins
Therapeutic Index
Narrow
Margin between therapeutic and toxic doses